LAMEA Bone Growth Stimulators Market By Product, By Application, By Distribution Channel, By Country, Industry Analysis and Forecast, 2020 - 2026

The Latin America, Middle East and Africa Bone Growth Stimulators Market is expected to witness market growth of 8% CAGR during the forecast period (2020-2026).

Bone growth stimulation is used to facilitate bone healing in fractures or fusions that are difficult to heal by applying electrical or ultrasonic current to the fracture/fusion site. An electrical osteogenesis stimulator is a tool that provides electrical stimulation to improve bone repair. Electrical stimulation may be performed either from the outside of the body (non-invasive) or from the inside of the body (invasive).

A non-invasive electrical stimulator is characterized by an external power source that is connected to a coil or electrodes mounted on the skin or on casting or brace over a fracture or fusion site. The ultrasonic osteogenesis stimulator is a non-invasive system that emits low pressure, pulsed ultrasound. The ultrasound signal is applied to the surface of the skin at the fracture site using an ultrasound conductive coupling gel to facilitate fracture healing.

External bone stimulation systems are worn out of the skin and do not need surgical implantation or extraction. In comparison to an internal (implanted) bone growth stimulator, an external bone growth stimulator can also be used for use by the patient several weeks or months after fusion surgery if the bone is not healed as desired.

The market for bone growth stimulators is mainly driven by factors such as the occurrence of bone and joint disorders, the demand for non-invasive and minimally invasive surgery across the globe, among others. Globally, osteoarthritis is the most common articular condition in people 65 years of age and older. Moreover, growing numbers of injuries and injury cases are considered to be one of the high-impact factors likely to fuel demand for bone growth stimulator products.

Based on Product, the market is segmented into Bone Growth Stimulation Devices, Bone Morphogenetic Proteins and Platelet-Rich Plasma. Based on Application, the market is segmented into Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries and Others. Based on Distribution Channel, the market is segmented into Hospitals & Clinics, Home Care and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson, Medtronic PLC, Zimmer Biomet Holdings, Inc., Stryker Corporation, Smith & Nephew PLC, Terumo Corporation (Terumo BCT, Inc.), Colfax Corporation (DJO Global, Inc.), Orthofix Medical, Inc., Arthrex, Inc., Bioventus LLC

Scope of the Study

Market Segmentation:

By Product

• Bone Growth Stimulation Devices
• Bone Morphogenetic Proteins and
• Platelet-Rich Plasma

By Application

• Spinal Fusion Surgeries
• Delayed Union & Nonunion Bone Fractures
• Oral & Maxillofacial Surgeries and
• Others

By Distribution Channel

• Hospitals & Clinics
• Home Care and
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Companies Profiled:

• Johnson and Johnson
• Medtronic PLC
• Zimmer Biomet Holdings, Inc.
• Stryker Corporation
• Smith & Nephew PLC
• Terumo Corporation (Terumo BCT, Inc.)
• Colfax Corporation (DJO Global, Inc.)
• Orthofix Medical, Inc.
• Arthrex, Inc.
• Bioventus LLC

Unique Offerings from the Publisher:

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free